MedImmune FluMist Flyer Cited By FDA Warning Letter For Lacking Risk Information
This article was originally published in The Pink Sheet Daily
Executive Summary
The company must develop a plan of action to distribute non-misleading information to consumers that received the promotional material for the intranasal flu vaccine, the agency says. The flyer does not include contraindications, warnings or directions for use for FluMist, the letter states.